Consensus $796.63M. Backs FY26 adjusted EBITDA view $55M-$57M.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NEO:
- NeoGenomics Inc. (NEO) Q1 Earnings Cheat Sheet
- NeoGenomics expands access to full oncology testing portfolio
- William Blair health diagnostics analyst holds analyst/industry conference call
- Morning Movers: National Storage surges following Public Storage buyout
- NeoGenomics PanTracer LBx test receives Medicare coverage